Regen Biopharma, Inc.

$rgbp Chart Analysis

144
upon review bullish divergence can be seen when combining rsi with price action
mac d is coming to retest

candles give off sign we''ve hit the bottom

huge buy of 30k today

descending triangle spotted that may break up or down

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

be careful trading against trends

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。